Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuanfu Daizhe Tang is a classical traditional Chinese medicinal prescription that has been widely used for hundreds of years to treat various digestive system illnesses, including reflux esophagitis, chronic gastritis, gastric ulcers, and hiccups. Research indicates that it alleviates reflux esophagitis by modulating the STAT1/TREM-1 pathway, inhibiting inflammatory responses, and decreasing levels of inflammatory cytokines. It also inhibits the expression of Claudin-4 and Claudin-5 and promotes the polarization of macrophages towards the M2 phenotype. Traditionally, it is understood to descend adverse Qi, dissolve phlegm, boost Qi, and harmonize the stomach.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xuanfu Daizhe Tang.